Skip to main content

Free UK delivery · Batch tested

CJC-1295 + Ipamorelin Blend — 98%+ purity research compound vial, UK stocked (HelixCore Peptides)
UK Stock

CJC-1295 + Ipamorelin Blend

Pre-mixed research blend of CJC-1295 (GHRH analogue) and Ipamorelin (ghrelin receptor agonist) supplied for in-vitro receptor and peptide-signalling research.

Purity

98%+ (per source specifications)

Form

Lyophilised Powder

Storage

-20°C lyophilised · store at 2–8°C once reconstituted

£39.99

Free UK delivery

1
In UK stock now · Free Royal Mail Tracked 24 delivery
Free tool: CJC-1295 + Ipamorelin Blend reconstitution calculator →
Research Use Only. Sold strictly for in-vitro laboratory research. Not for human or veterinary use, medical, therapeutic or diagnostic application.
Plain packaging suitable for laboratory deliveries.

About CJC-1295 + Ipamorelin Blend

What it is

A single vial containing CJC-1295 (No DAC) and Ipamorelin together. The two are studied as a pair because they act on different receptors within the same endocrine axis, which is a common design in laboratory work on pulsatile hormone release.

How it is understood to work

CJC-1295 without DAC is a modified growth-hormone-releasing hormone analogue acting at the GHRH receptor; Ipamorelin acts at the growth-hormone secretagogue receptor. Two receptors, one axis. Research combining them examines whether stimulating both produces a different release profile than either alone.

What research has looked at

Pituitary cell models and animal endocrine studies looking at release amplitude and pattern. There is less published work on the specific combination than on either component.

Handling and storage

Both peptides are in one vial at a fixed ratio, so they cannot be varied independently. Reconstitute once; refrigerate; avoid freeze-thaw cycling.

Supplied for in-vitro laboratory research only. Nothing above describes a dose, a protocol, or a use in humans or animals, and none of these compounds is a licensed medicine in the UK.

Research Information

The CJC-1295 + Ipamorelin Blend combines two growth hormone secretagogue research peptides — a GHRH analogue (CJC-1295 No DAC) and a selective ghrelin receptor agonist (Ipamorelin) — into a single research vial. Both are studied for their role in pituitary growth hormone signalling research. Researchers are interested in their combined effect on growth hormone release pathways in pituitary cell models, an area that has informed broader research on growth factor signalling and metabolic regulation.

Research areas

  • Pituitary cell-line research
  • Combined GHRH/ghrelin pathway studies
  • Growth hormone secretion model research
  • Comparative secretagogue studies

Analytical methods

Identity and purity are typically confirmed at source by high-performance liquid chromatography (HPLC) and mass spectrometry.

Storage and handling

Store lyophilised at -20°C, away from moisture and direct light. Once reconstituted, store at 2–8°C and use within the timeframe specified on the source datasheet.

For Research Use Only. Not for human or veterinary use.

Batch tested

Every batch is tested for identity and purity, and we publish the certificate.

UK dispatch

UK-stocked. Orders placed before 2pm dispatch the same business day via Royal Mail Tracked 24. Free UK shipping on every order. We ship to UK addresses only.

Frequently asked questions